UniProt ID | FKBP8_HUMAN | |
---|---|---|
UniProt AC | Q14318 | |
Protein Name | Peptidyl-prolyl cis-trans isomerase FKBP8 | |
Gene Name | FKBP8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 412 | |
Subcellular Localization |
Mitochondrion . Mitochondrion membrane Single-pass membrane protein Cytoplasmic side . Isoform 1: Mitochondrion membrane Single-pass membrane protein Cytoplasmic side . Isoform 3: Mitochondrion membrane Single-pass membrane protein Cytoplasmic |
|
Protein Description | Constitutively inactive PPiase, which becomes active when bound to calmodulin and calcium. Seems to act as a chaperone for BCL2, targets it to the mitochondria and modulates its phosphorylation state. The BCL2/FKBP8/calmodulin/calcium complex probably interferes with the binding of BCL2 to its targets. The active form of FKBP8 may therefore play a role in the regulation of apoptosis.. | |
Protein Sequence | MASCAEPSEPSAPLPAGVPPLEDFEVLDGVEDAEGEEEEEEEEEEEDDLSELPPLEDMGQPPAEEAEQPGALAREFLAAMEPEPAPAPAPEEWLDILGNGLLRKKTLVPGPPGSSRPVKGQVVTVHLQTSLENGTRVQEEPELVFTLGDCDVIQALDLSVPLMDVGETAMVTADSKYCYGPQGRSPYIPPHAALCLEVTLKTAVDGPDLEMLTGQERVALANRKRECGNAHYQRADFVLAANSYDLAIKAITSSAKVDMTFEEEAQLLQLKVKCLNNLAASQLKLDHYRAALRSCSLVLEHQPDNIKALFRKGKVLAQQGEYSEAIPILRAALKLEPSNKTIHAELSKLVKKHAAQRSTETALYRKMLGNPSRLPAKCPGKGAWSIPWKWLFGATAVALGGVALSVVIAARN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
105 | Ubiquitination | GNGLLRKKTLVPGPP CCCCCCCCEECCCCC | 40.43 | - | |
106 | Phosphorylation | NGLLRKKTLVPGPPG CCCCCCCEECCCCCC | 35.70 | 23312004 | |
112 | Ubiquitination | KTLVPGPPGSSRPVK CEECCCCCCCCCCCC | 62.30 | 21890473 | |
114 | Ubiquitination | LVPGPPGSSRPVKGQ ECCCCCCCCCCCCCC | 29.02 | - | |
125 | Ubiquitination | VKGQVVTVHLQTSLE CCCCEEEEEEEEECC | 2.61 | - | |
148 | Ubiquitination | PELVFTLGDCDVIQA CEEEEEECCCCHHHH | 30.37 | - | |
155 | Ubiquitination | GDCDVIQALDLSVPL CCCCHHHHCCCCCEE | 7.60 | 21890473 | |
175 | Ubiquitination | TAMVTADSKYCYGPQ EEEEECCCCCCCCCC | 24.06 | - | |
181 | Ubiquitination | DSKYCYGPQGRSPYI CCCCCCCCCCCCCCC | 13.64 | - | |
189 | Ubiquitination | QGRSPYIPPHAALCL CCCCCCCCHHHHHHH | 14.58 | - | |
211 | Sulfoxidation | VDGPDLEMLTGQERV CCCCCHHHHCCHHHH | 5.44 | 21406390 | |
232 | Phosphorylation | RECGNAHYQRADFVL CCCCCCHHHHCCEEE | 9.40 | 28796482 | |
249 | Ubiquitination | NSYDLAIKAITSSAK CCHHHHHHHHHCCCC | 28.29 | 21906983 | |
249 (in isoform 1) | Ubiquitination | - | 28.29 | 21890473 | |
250 (in isoform 2) | Ubiquitination | - | 12.27 | - | |
259 | Sulfoxidation | TSSAKVDMTFEEEAQ HCCCCCCCCHHHHHH | 5.32 | 21406390 | |
265 | Phosphorylation | DMTFEEEAQLLQLKV CCCHHHHHHHHHHHH | 14.48 | 15592455 | |
271 | Acetylation | EAQLLQLKVKCLNNL HHHHHHHHHHHHHHH | 27.04 | 26051181 | |
271 | Methylation | EAQLLQLKVKCLNNL HHHHHHHHHHHHHHH | 27.04 | - | |
271 | Ubiquitination | EAQLLQLKVKCLNNL HHHHHHHHHHHHHHH | 27.04 | 21890473 | |
271 (in isoform 1) | Ubiquitination | - | 27.04 | 21890473 | |
272 (in isoform 2) | Ubiquitination | - | 7.81 | 21890473 | |
273 | Malonylation | QLLQLKVKCLNNLAA HHHHHHHHHHHHHHH | 31.27 | 26320211 | |
273 | Ubiquitination | QLLQLKVKCLNNLAA HHHHHHHHHHHHHHH | 31.27 | 25621951 | |
273 | 2-Hydroxyisobutyrylation | QLLQLKVKCLNNLAA HHHHHHHHHHHHHHH | 31.27 | - | |
274 (in isoform 2) | Ubiquitination | - | 5.72 | - | |
278 (in isoform 2) | Ubiquitination | - | 4.02 | 21890473 | |
281 | Phosphorylation | CLNNLAASQLKLDHY HHHHHHHHHHCHHHH | 30.36 | 28857561 | |
284 | Ubiquitination | NLAASQLKLDHYRAA HHHHHHHCHHHHHHH | 44.20 | 25621951 | |
284 | Acetylation | NLAASQLKLDHYRAA HHHHHHHCHHHHHHH | 44.20 | 26051181 | |
285 (in isoform 2) | Ubiquitination | - | 7.16 | - | |
288 | Phosphorylation | SQLKLDHYRAALRSC HHHCHHHHHHHHHHC | 11.12 | - | |
294 | Phosphorylation | HYRAALRSCSLVLEH HHHHHHHHCCEEECC | 14.65 | 30266825 | |
296 | Phosphorylation | RAALRSCSLVLEHQP HHHHHHCCEEECCCC | 23.82 | 23401153 | |
297 (in isoform 2) | Phosphorylation | - | 6.30 | 24719451 | |
300 (in isoform 2) | Ubiquitination | - | 32.75 | 21890473 | |
307 | Ubiquitination | EHQPDNIKALFRKGK CCCCCCHHHHHHHCC | 45.34 | 21906983 | |
307 | 2-Hydroxyisobutyrylation | EHQPDNIKALFRKGK CCCCCCHHHHHHHCC | 45.34 | - | |
307 | Acetylation | EHQPDNIKALFRKGK CCCCCCHHHHHHHCC | 45.34 | 26051181 | |
307 (in isoform 1) | Ubiquitination | - | 45.34 | 21890473 | |
308 (in isoform 2) | Ubiquitination | - | 14.24 | - | |
314 (in isoform 1) | Ubiquitination | - | 36.79 | 21890473 | |
314 | Ubiquitination | KALFRKGKVLAQQGE HHHHHHCCEEHHCCC | 36.79 | 2189047 | |
315 (in isoform 2) | Ubiquitination | - | 7.94 | 21890473 | |
322 | Phosphorylation | VLAQQGEYSEAIPIL EEHHCCCHHHHHHHH | 20.73 | 28796482 | |
323 | Phosphorylation | LAQQGEYSEAIPILR EHHCCCHHHHHHHHH | 19.09 | 28796482 | |
334 | Malonylation | PILRAALKLEPSNKT HHHHHHHCCCCCCCC | 46.18 | 26320211 | |
334 | Acetylation | PILRAALKLEPSNKT HHHHHHHCCCCCCCC | 46.18 | 25953088 | |
334 | Ubiquitination | PILRAALKLEPSNKT HHHHHHHCCCCCCCC | 46.18 | 25621951 | |
335 (in isoform 2) | Ubiquitination | - | 14.06 | - | |
336 (in isoform 2) | Ubiquitination | - | 45.13 | 21890473 | |
340 | Malonylation | LKLEPSNKTIHAELS HCCCCCCCCHHHHHH | 53.87 | 26320211 | |
340 | Ubiquitination | LKLEPSNKTIHAELS HCCCCCCCCHHHHHH | 53.87 | 25621951 | |
341 | Phosphorylation | KLEPSNKTIHAELSK CCCCCCCCHHHHHHH | 23.42 | 23312004 | |
341 (in isoform 2) | Ubiquitination | - | 23.42 | - | |
343 (in isoform 2) | Ubiquitination | - | 20.55 | 21890473 | |
347 | Phosphorylation | KTIHAELSKLVKKHA CCHHHHHHHHHHHHH | 18.56 | 30108239 | |
348 | Acetylation | TIHAELSKLVKKHAA CHHHHHHHHHHHHHH | 70.67 | 25953088 | |
348 | Ubiquitination | TIHAELSKLVKKHAA CHHHHHHHHHHHHHH | 70.67 | 19608861 | |
348 | Malonylation | TIHAELSKLVKKHAA CHHHHHHHHHHHHHH | 70.67 | 26320211 | |
348 (in isoform 2) | Phosphorylation | - | 70.67 | 27251275 | |
349 | Acetylation | IHAELSKLVKKHAAQ HHHHHHHHHHHHHHH | 6.49 | 19608861 | |
349 (in isoform 2) | Ubiquitination | - | 6.49 | - | |
351 | Ubiquitination | AELSKLVKKHAAQRS HHHHHHHHHHHHHHH | 49.64 | 25621951 | |
352 | Ubiquitination | ELSKLVKKHAAQRST HHHHHHHHHHHHHHH | 30.88 | 25621951 | |
358 | Phosphorylation | KKHAAQRSTETALYR HHHHHHHHHHHHHHH | 20.65 | 21815630 | |
359 | Phosphorylation | KHAAQRSTETALYRK HHHHHHHHHHHHHHH | 39.27 | 30108239 | |
361 | Phosphorylation | AAQRSTETALYRKML HHHHHHHHHHHHHHH | 23.27 | 28796482 | |
364 | Phosphorylation | RSTETALYRKMLGNP HHHHHHHHHHHHCCH | 13.01 | 25884760 | |
366 | Ubiquitination | TETALYRKMLGNPSR HHHHHHHHHHCCHHH | 25.56 | - | |
372 | Phosphorylation | RKMLGNPSRLPAKCP HHHHCCHHHCCCCCC | 50.91 | 28857561 | |
377 | Ubiquitination | NPSRLPAKCPGKGAW CHHHCCCCCCCCCCC | 38.74 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FKBP8_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FKBP8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FKBP8_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-348, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-322, AND MASSSPECTROMETRY. |